» Articles » PMID: 34021586

NLRP7: From Inflammasome Regulation to Human Disease

Overview
Journal Immunology
Date 2021 May 22
PMID 34021586
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Nucleotide-binding oligomerization domain (NOD) and leucine-rich repeat (LRR)-containing receptors or NOD-like receptors (NLRs) are cytosolic pattern recognition receptors, which sense conserved microbial patterns and host-derived danger signals to elicit innate immune responses. The activation of several prototypic NLRs, including NLR and pyrin domain (PYD) containing (NLRP) 1, NLRP3 and NLR and caspase recruitment domain (CARD) containing (NLRC) 4, results in the assembly of inflammasomes, which are large, cytoplasmic multiprotein signalling platforms responsible for the maturation and release of the pro-inflammatory cytokines IL-1β and IL-18, and for the induction of a specialized form of inflammatory cell death called pyroptosis. However, the function of other members of the NLR family, including NLRP7, are less well understood. NLRP7 has been linked to innate immune signalling, but its precise role is still controversial as it has been shown to positively and negatively affect inflammasome responses. Inflammasomes are essential for homeostasis and host defence, but inappropriate inflammasome responses due to hereditary mutations and somatic mosaicism in inflammasome components and defective regulation have been linked to a broad spectrum of human diseases. A compelling connection between NLRP7 mutations and reproductive diseases, and in particular molar pregnancy, has been established. However, the molecular mechanisms by which NLRP7 mutations contribute to reproductive diseases are largely unknown. In this review, we focus on NLRP7 and discuss the current evidence of its role in inflammasome regulation and its implication in human reproductive diseases.

Citing Articles

High cumulative glucocorticoid dose is associated with increased levels of inflammation-related mediators in active rheumatoid arthritis.

Petrackova A, Horak P, Savara J, Skacelova M, Kriegova E Front Immunol. 2025; 15:1505615.

PMID: 39744635 PMC: 11688219. DOI: 10.3389/fimmu.2024.1505615.


Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis.

Pandey A, Li Z, Gautam M, Ghosh A, Man S Immunol Rev. 2024; 329(1):e13406.

PMID: 39351983 PMC: 11742652. DOI: 10.1111/imr.13406.


Implication of the LRR Domain in the Regulation and Activation of the NLRP3 Inflammasome.

Cescato M, Zhu Y, Le Corre L, Py B, Georgin-Lavialle S, Rodero M Cells. 2024; 13(16).

PMID: 39195255 PMC: 11352923. DOI: 10.3390/cells13161365.


Unraveling the role of NLRP3 inflammasome in allergic inflammation: implications for novel therapies.

Lu H, Zhou Y, Hu T, Yang D, Wang X, Luo D Front Immunol. 2024; 15:1435892.

PMID: 39131161 PMC: 11310156. DOI: 10.3389/fimmu.2024.1435892.


HLA-C expression in extravillous trophoblasts is determined by an ELF3-NLRP2/NLRP7 regulatory axis.

Gu B, Le G, Herrera S, Blair S, Meissner T, Strominger J Proc Natl Acad Sci U S A. 2024; 121(31):e2404229121.

PMID: 39052836 PMC: 11295039. DOI: 10.1073/pnas.2404229121.


References
1.
Tsai P, Chen K, Li Y, Kuo P . Is Involved in the Differentiation of the Decidual Macrophages. Int J Mol Sci. 2019; 20(23). PMC: 6929161. DOI: 10.3390/ijms20235994. View

2.
Lamkanfi M, Denecker G, Kalai M, DHondt K, Meeus A, Declercq W . INCA, a novel human caspase recruitment domain protein that inhibits interleukin-1beta generation. J Biol Chem. 2004; 279(50):51729-38. DOI: 10.1074/jbc.M407891200. View

3.
Tucci V, Isles A, Kelsey G, Ferguson-Smith A . Genomic Imprinting and Physiological Processes in Mammals. Cell. 2019; 176(5):952-965. DOI: 10.1016/j.cell.2019.01.043. View

4.
Johnson D, Taabazuing C, Okondo M, Chui A, Rao S, Brown F . DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia. Nat Med. 2018; 24(8):1151-1156. PMC: 6082709. DOI: 10.1038/s41591-018-0082-y. View

5.
Benko S, Magalhaes J, Philpott D, Girardin S . NLRC5 limits the activation of inflammatory pathways. J Immunol. 2010; 185(3):1681-91. DOI: 10.4049/jimmunol.0903900. View